Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Spanish mothers more concerned about the safety of childhood vaccines

Researchers from the University of Alicante (UA) taking part in the European VACSATC project have studied mothers' and fathers' opinions on vaccinating their children in five countries. The results of the survey show that Spanish mothers are more resistant than those in other countries to the idea of paying for vaccines, while 20.9% expressed some concern about the safety of vaccines.

8 Oct 2010

CDC issues new universal influenza vaccination recommendation for all Americans

With the influenza vaccine already available and more supply anticipated than ever before, the National Foundation for Infectious Diseases convened ten of the country's leading medical and public health groups to call on all Americans to get vaccinated this season.

8 Oct 2010

Firm sees drugs sales rising 5 to 7 percent next year, other drug industry news

The Associated Press reports that global prescription drug sales should rise 5 percent to 7 percent next year reaching at least $880 billion, fueled by new drugs and rising sales in developing countries, according to drug data firm IMS Health.

8 Oct 2010

Scientists engineer bacterial cell wall with small molecules to combat diseases

A team of Yale University scientists has engineered the cell wall of the Staphylococcus aureus bacteria, tricking it into incorporating foreign small molecules and embedding them within the cell wall.

8 Oct 2010

Emergent BioSolutions and TLV form new joint venture to develop flu vaccines

Emergent BioSolutions Inc., a U.S.-based developer and manufacturer of vaccines and antibody therapies, today launched its Singapore operations.

8 Oct 2010

ABC news announces one-year reporting series on global health issues

ABC News on Wednesday announced a yearlong project to focus attention on the diseases and health conditions that afflict the world's poorest people the Associated Press reports.

8 Oct 2010

U.N. Secretary-General urges funding for GAVI during replenishment meeting

U.N. Secretary-General Ban Ki-moon has urged more funding for the GAVI Alliance to help achieve its childhood vaccine targets and the related Millennium Development Goals (MDGs), TopNews reports.

8 Oct 2010

International scientific conference explores new approaches to prevent infectious diseases

Swine flu, cancer, bioterrorism and the latest trends in countermeasures to combat these life-threatening diseases and infections are among the topics to be discussed at the upcoming New Cells for New Vaccines V: Global Perspectives international scientific conference, on October 11-13 in Wilmington, Delaware, at the Hotel du Pont.

8 Oct 2010

Inviragen, PharmaJet awarded NIAID contract to develop needle-free, easy to administer dengue vaccine

Inviragen and PharmaJet announced the award of a five year, $15.5 million dollar contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to advance the development of a needle-free, easy to administer dengue vaccine. The award will fund preclinical studies, regulatory filings, manufacturing and clinical testing of Inviragen's tetravalent dengue vaccine, DENVax delivered with PharmaJet's convenient needle-free injection device.

8 Oct 2010

Mass. attorney general recommends approval of Caritas sale; Calif. will require students to get whooping cough vaccine

Attorney General Martha Coakley yesterday recommended approval of the proposed sale of Caritas Christi Health Care to a New York private equity firm, a deal that would bring for-profit health care on a large scale to a state long dominated by nonprofit hospitals.

8 Oct 2010

First Edition: October 7, 2010

Today's headlines include stories on waivers given some companies that offer only minimal health insurance coverage, insurers' political efforts during this campaign season and efforts in New York to bar the use of food stamps to buy soda.

7 Oct 2010

Hizentra therapy effective for primary immunodeficiency patients

Hizentra (IgPro20) provides primary immunodeficiency (PI) patients with a safe and effective alternative to other immunoglobulin therapies when given in equivalent doses, according to Phase III pivotal trial data presented today at the XIVth Meeting of the European Society for Immunodeficiencies (ESID).

7 Oct 2010

Health care votes haunt anti-abortion Dems; Republicans confront challenges with 'pledge'

Anti-abortion Democrats are facing stiff opposition in their bids for re-election because of their votes for health reform. Organizations like the Susan B. Anthony List and other anti-abortion groups are now attacking former allies who once sided with them on abortion. "Now, SBA List is engaged in a multimillion-dollar attack on its former allies, replete with bus tours and billboards alleging that members 'voted for taxpayer-funded abortion.'

7 Oct 2010

Study explains importance of identifying global pandemic risk factors to predict spread of diseases

A recent study led by Dr. Parviez Hosseini, a senior research fellow from EcoHealth Alliance (formerly Wildlife Trust), explains the importance of identifying global pandemic risk factors as early as possible, in order to predict the spread of diseases like H1N1 "swine" flu and SARS. "Predictive Power of Air Travel and Socio-Economic data for Early Pandemic Spread," recently published in the scientific publication PLoS ONE, examines the interplay among travel, trade, and national healthcare resources in predicting the emergence and spread of H1N1 and other viruses.

7 Oct 2010

Synthetic Genomics, JCVI announce formation of new company to develop next generation vaccines

The company Synthetic Genomics Inc. (SGI) and the not-for-profit research organization, the J. Craig Venter Institute (JCVI) today announced the formation of a new company, Synthetic Genomics Vaccines Inc. (SGVI).

7 Oct 2010

VAP bundle helps eliminate hospital-acquired infection

Critically ill patients on a breathing tube are at risk not only from their injuries or diseases, but also from infections they can contract in the hospital. One of the most common infections is pneumonia from breathing tubes. A study of a new multidisciplinary protocol that has all but eliminated such infections at one hospital was reported on today at the 2010 Annual Clinical Congress of the American College of Surgeons.

7 Oct 2010

Pharmaxis receives FDA approval to market ARIDOL Test Kit

Pharmaxis, a global specialty pharmaceutical company focused on therapeutic products for chronic respiratory and immune disorders, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market ARIDOL™ (mannitol inhalation powder) Bronchial Challenge Test Kit, the first new bronchial challenge test in more than two decades.

7 Oct 2010

American Cancer Society awards 94 national research, training grants to 70 institutions nationwide

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 94 national research and training grants totaling $46,633,000 to 70 institutions nationwide in the first of two grants cycles for 2011.

7 Oct 2010

Johnson & Johnson to acquire all outstanding equity of Crucell for euro 1.75 billion

Johnson & Johnson and Crucell N.V. today announced an agreement whereby Johnson & Johnson, through an affiliate, would acquire all outstanding equity of Crucell that it does not already own for approximately euro 1.75 billion in a recommended cash tender offer.

6 Oct 2010

Amgen to present oncology portfolio results at ESMO Congress

Amgen today announced that results from several important studies from the Company's ncology portfolio will be presented at the 35th European Society for Medical Oncology (ESMO) Congress, Oct. 8-12, 2010, in Milan, Italy.

6 Oct 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Spanish mothers more concerned about the safety of childhood vaccines

CDC issues new universal influenza vaccination recommendation for all Americans

Firm sees drugs sales rising 5 to 7 percent next year, other drug industry news

Scientists engineer bacterial cell wall with small molecules to combat diseases

Emergent BioSolutions and TLV form new joint venture to develop flu vaccines

ABC news announces one-year reporting series on global health issues

U.N. Secretary-General urges funding for GAVI during replenishment meeting

International scientific conference explores new approaches to prevent infectious diseases

Inviragen, PharmaJet awarded NIAID contract to develop needle-free, easy to administer dengue vaccine

Mass. attorney general recommends approval of Caritas sale; Calif. will require students to get whooping cough vaccine

First Edition: October 7, 2010

Hizentra therapy effective for primary immunodeficiency patients

Health care votes haunt anti-abortion Dems; Republicans confront challenges with 'pledge'

Study explains importance of identifying global pandemic risk factors to predict spread of diseases

Synthetic Genomics, JCVI announce formation of new company to develop next generation vaccines

VAP bundle helps eliminate hospital-acquired infection

Pharmaxis receives FDA approval to market ARIDOL Test Kit

American Cancer Society awards 94 national research, training grants to 70 institutions nationwide

Johnson & Johnson to acquire all outstanding equity of Crucell for euro 1.75 billion

Amgen to present oncology portfolio results at ESMO Congress

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in